IGA NEPHROPATHY (IGAN)
Clinical trials for IGA NEPHROPATHY (IGAN) explained in plain language.
Never miss a new study
Get alerted when new IGA NEPHROPATHY (IGAN) trials appear
Sign up with your email to follow new studies for IGA NEPHROPATHY (IGAN), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New pill shows promise for kidney disease patients
Disease control CompletedThis study tested a new drug called HSK39297 in 87 adults with IgA nephropathy, a kidney disease. The goal was to see if the drug could lower protein levels in urine, a sign of kidney damage, compared to a placebo. Participants took the drug or placebo for up to 24 weeks, and res…
Matched conditions: IGA NEPHROPATHY (IGAN)
Phase: PHASE2 • Sponsor: Haisco Pharmaceutical Group Co., Ltd. • Aim: Disease control
Last updated Jun 22, 2026 11:54 UTC
-
Could your gut and kidneys affect your brain? new study explores link in kidney disease
Knowledge-focused CompletedThis completed study looked at why people with IgA nephropathy (a kidney disease) often experience memory and thinking problems. Researchers used advanced MRI scans, along with blood and stool samples, to examine connections between the brain, gut, and kidneys in 100 patients and…
Matched conditions: IGA NEPHROPATHY (IGAN)
Sponsor: Tang-Du Hospital • Aim: Knowledge-focused
Last updated Jun 23, 2026 11:56 UTC